Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.36.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.243NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
R.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.216NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.471NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.420NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
L.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.518NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.551NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.207NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.604NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.111NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.619NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.36.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.36.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.23.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.316NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.436NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.561NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.605NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.596NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
W.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.565NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.361NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.101NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.478NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.383NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.95 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.189NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
C.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.545NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.482NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.186NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.324NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.322NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.160.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.416NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.239NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used